South Korea's Industrial Output Declined 0.7% in November, Export Slowdown and Weakened Business Confidence
According to government data released on Monday, South Korea's industrial output decline in November exceeded expectations, primarily due to a slowdown in exports and weakened business confidence. Specifically, the seasonally adjusted industrial output index (KRIO=ECI) fell by 0.7% month-on-month, while the previous month's data remained unchanged. In contrast, a Reuters survey of economists had anticipated a decline of 0.4%.
Statistics Korea reported that compared to the same period last year, the index only increased by 0.1%, far below last month's 6.3% increase and the economists' expectation of 0.4%.
Additionally, South Korea's export growth rate slowed to its lowest level in 14 months, especially exports to the United States and China, which fell due to tariff uncertainties. Meanwhile, the country's business confidence index dropped to its lowest point in over four years.
2026-10-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
LB Group Takes Over UK Titanium Dioxide Plant, Restarts 150,000-tonne Capacity
-
Evonik to Close Two German Plants, Further Cutting Europe’s High-Purity Silicon Tetrachloride Capacity
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
-
When BASF Lets Agriculture Fly Solo: A Capital Repricing of Scale and Ambition
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
AstraZeneca and CSPC Strengthen Biologics Manufacturing Partnership in China
Recommend Reading
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
China Activates Blocking Rules in Response to U.S. Sanctions on Petrochemical Firms
-
Solar Industries Offers $1.355 Billion for South Africa’s Omnia in Global Mining Chemicals Expansion
-
Business Society’s September 14, 2026 Phenol Market Outlook: Strong Consolidation
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Premium Global Chemical Sourcing Requests (10-13Sep.,2026)
-
October Ethyl Acetate Price Trends: Rising First, Then Falling
-
China's Epoxy Resins Market Weakens and Declines